116 (1) Modified nucleotides shall be listed in the sequence as “N”, with further information given elsewhere in the sequence listing.
(2) For the purpose of providing the further information referred to in subsection (1), the symbols set out in the table to this subsection may be used.
Symbol Meaning ac4c 4-acetylcytidine chm5u 5-(carboxyhydroxymethyl) uridine cm 2’-O-methylcytidine cmnm5s2u 5-carboxymethylaminomethyl-2-thiouridine cmnm5u 5-carboxymethylaminomethyluridine d dihydrouridine fm 2’-O-methylpseudouridine gal q beta, D-galactosylqueuosine gm 2’-O-methylguanosine i inosine i6a N6-isopentenyladenosine m1a 1-methyladenosine m1f 1-methylpseudouridine m1g 1-methylguanosine m1i 1-methylinosine m22g 2,2-dimethylguanosine m2a 2-methyladenosine m2g 2-methylguanosine m3c 3-methylcytidine m5c 5-methylcytidine m6a N6-methyladenosine m7g 7-methylguanosine mam5u 5-methylaminomethyluridine mam5s2u 5-methoxyaminomethyl-2-thiouridine man q beta, D-mannosylqueuosine mcm5s2u 5-methoxycarbonylmethyl-2-thiouridine mcm5u 5-methoxycarbonylmethyluridine mo5u 5-methoxyuridine ms2i6a 2-methylthio-N6-isopentenyladenosine ms2t6a N-((9-beta-D-ribofuranosyl-2-methylthiopurine-6-yl) carbamoyl) threonine mt6a N-((9-beta-D-ribofuranosylpurine-6-yl) N-methycarbamoy1) threonine mv uridine-5-oxyacetic acid-methylester o5u uridine-5-oxyacetic acid (v) osyw wybutoxosine p pseudouridine q queuosine s2c 2-thiocytidine s2t 5-methyl-2-thiouridine s2u 2-thiouridine s4u 4-thiouridine t 5-methyluridine t6a N-((9-beta-D-ribofuranosylpurine-6-yl) - carbamoyl) threonine tm 2’-O-methyl-5-methyluridine um 2’-O-methyluridine yw wybutosine x 3-(3-amino-3-carboxy-propyl) uridine, (acp3) u
- Date modified: